Chapter 026

Antianginal Drugs

Eileen L. Watson and Frank J. Dowd

CITED REFERENCES

  1. Abozguia K, Clarke K, Lee L, et al: Modification of myocardial substrate use as a therapy for heart failure. Nat Clin Pract Cardiovasc Med 3:490-498, 2006. PUBMED Abstract
  2. Arthur RM, Mehmel H: A sustained release formulation of isosorbide-5-mononitrate with a rapid onset of action. Int J Clin Pract 53:205-212, 1999. PUBMED Abstract
  3. Belardinelli R: Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Rev Port Cardiol 19(Suppl 5):V35-V39, 2000. PUBMED Abstract
  4. Butler RT, Kalkwarf KL, Kaldahl WB: Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc 114:56-60, 1987. PUBMED Abstract
  5. Chaitman BR: Pharmacological approaches to the symptomatic treatment of chronic stable angina: a historical perspective and future directions. Can J Cardiol 21:1031-1034, 2006. PUBMED Abstract
  6. Chen Z, Foster MW, Zhang J, et al: An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A 102:12159-12164, 2005. PUBMED Abstract
  7. Cheng JWM: Ranolazine for the management of coronary artery disease. Clin Therap 28:1996-2007, 2006. PUBMED Abstract
  8. Epstein BJ, Gums JG: Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations. Ann Pharmacother 39:470-480, 2005. PUBMED Abstract
  9. Gebalska J, Wolk R, Ceremuzynski L: Isosorbide dinitrate inhibits platelet adhesion and aggregation in nonthrombolyzed patients with acute myocardial infarction. Clin Cardiol 23:837-841, 2000. PUBMED Abstract
  10. Hitzeman N: Early invasive therapy or conservative management for unstable angina or NSTEMI? Am Fam Physician 75:47-49, 2007.
  11. Mishra B, Jackson G: Unstable angina: a review and practical guide to management. Int J Clin Pract 53:530-534, 1999. PUBMED Abstract
  12. Murad F: Shattuck lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 355:2003-2011, 2006. PUBMED Abstract
  13. Roe MT, Sapp SK, Lincoff AM: Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Cleve Clin J Med 67:131-140, 2000. PUBMED Abstract
  14. Siddiqui MA, Keam SJ: Ranolazine: a review of its use in chronic stable angina pectoris. Drugs 66:693-710, 2006. PUBMED Abstract
  15. Szwed H, Sadowski Z, Elikowski W, et al: Combination therapy in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in Poland. Eur Heart J 22:2267-2274, 2001. PUBMED Abstract
  16. Thadani U, Rodgers T: Side effects of nitrates to treat angina. Expert Opin Drug Saf 5:667-674, 2006. PUBMED Abstract
  17. Weir MR: Providing end-organ protection with renin-angiotensin system inhibition: the evidence so far. J Clin Hypertens 8:99-105, 2006. PUBMED Abstract
  18. Yeghiazarians Y, Braunstein JB, Askari A, et al: Unstable angina pectoris. N Engl J Med 342:101-114, 2000.

GENERAL REFERENCES

  1. Atwater BD, Roe MT, Mahaffey KW: Platelet glycoprotein IIb/IIa receptor antagonists in non-ST segment elevation acute coronary syndromes: a review and guide to patient selection, Drugs 65:313-324, 2005.
  2. Dagenais GR, Pogue J, Fox K, et al: Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials, Lancet 368:581-588, 2006.
  3. Mehta RH, Roe MT, Chen AY, et al: Recent trends in the care of patients with non-ST segment elevation acute coronary syndromes: insights from the CRUSADE initiative, Arch Intern Med 166:2027-2034, 2006. PUBMED Abstract